Navigation Links
AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
Date:11/13/2008

reciation and

amortization:

Property, plant and

equipment 433 426 1,199 1,183

Intangible assets 839 1,024 2,555 3,014

-------------------------------------------------------------------------

23,415 20,422 77,303 54,686

-------------------------------------------------------------------------

Loss from operations (12,386) (9,379) (46,069) (22,858)

Other income (expenses)

Interest income 149 494 737 1,369

Interest expense - (15) (68) (68)

Foreign exchange (loss)

gain (1,324) (170) 429 (766)

Loss on disposal of

long-lived assets held

for sale (90) - (125) -

-------------------------------------------------------------------------

(1,265) 309 973 535

-------------------------------------------------------------------------

Loss before income taxes (13,651) (9,070) (45,096) (22,323)

Income tax (expense)

recovery (228) 1,012 (228) 4,287

-------------------------------------------------------------------------

Net loss from continuing

operations (13,879) (8,058) (45,324) (18,036)

Net loss from

discontinued operations - (646) - (624)

-------------------------------------------------------------------------

Net loss for the period (13,879) (8,704) (45,324) (18,660)

-------------------------------------------------------------------------

----------------------------------------------------------------
'/>"/>

SOURCE AETERNA ZENTARIS INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
2. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
3. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
4. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
5. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
6. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
7. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
8. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
9. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
10. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
11. AEterna Zentaris to Announce Second Quarter 2008 Financial and Operating Results on August 12, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... More than 5 million Americans are currently ... seniors will die with Alzheimer’s or another dementia, according ... shocked many Americans into looking for ways to improve ... age-related cognitive disorders. Jonathan Weisman, president of Biohack Pure, ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 The Microcompetition with ... major disease. One of these latent viruses is the Epstein ... arthritis (RA). Rheumatoid arthritis (RA) is a chronic inflammatory disease ... a study found that RA patients have high concentrations of ...
(Date:1/15/2014)... 2013 was a banner year of ... They saw continued independent research led by the team ... a $1 million grant from the Susanne Marcus Collins ... a peer reviewed journal, Amy Grant highlighted Brainwave Optimization® ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of ... of tinnitus. Patients listen to sound therapy that is ... of weeks to months, their tinnitus volume decreases. , AudioNotch ... Music and Notched White Noise. Now, AudioNotch is pleased to ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3
... The J. R. Simplot Company,s Plant Sciences ... for improving crops, leading to new, better and ...   Innate™ Technology is a patented ... own genes to enhance desirable traits and to ...
... SUNNYVALE, Calif., July 12, 2011 Molecular Devices ... discovery & development, life science research, and bioassay/test ... functionality of the SoftMax® Pro Software and prominence ... control ability via an Apple iPad wireless device. ...
... New research from the Trudeau Institute may help to ... lives of patients with sepsis. The study was led by ... shows that fibrin, a key product of the blood clotting ... , a gram-negative bacterium that causes sepsis in humans and ...
Cached Biology Technology:Molecular Devices Enables Intuitive Functionality at Your Fingertips on the Apple iPad with the Latest SoftMax Pro Software 2Trudeau Institute announces a discovery in the fight against sepsis 2
(Date:4/20/2014)... Most drugs used to treat lung, breast and pancreatic ... Researchers at the University of California, San Diego School ... CD61 on the surface of drug-resistant tumors that appears ... cell-like properties of cancer cells. , The findings, ... Nature Cell Biology , may point to new ...
(Date:4/20/2014)... crop residue to make ethanol and other biofuels reduces ... gasoline, according to a study published today in the ... by a University of Nebraska-Lincoln team of researchers cast ... meet federal mandates to ramp up ethanol production and ... stalks, leaves and cobs in cornfields after harvest -- ...
(Date:4/18/2014)... while feeding a world population predicted to reach ... approach to conservation that considers human-altered landscapes such ... and the natural habitat that supports it might ... where at least three-quarters of the land surface ... is vulnerable to human-caused impacts such as climate ...
Breaking Biology News(10 mins):Cancer stem cells linked to drug resistance 2Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Stanford researchers rethink 'natural' habitat for wildlife 2Stanford researchers rethink 'natural' habitat for wildlife 3Stanford researchers rethink 'natural' habitat for wildlife 4
... Hormone replacement therapies, or medications containing female hormones ... body, are often prescribed to reduce the effects ... women. Research and clinical trials on hormone replacement ... especially breast cancer, in post-menopausal women who take ...
... been elected as a fellow of the American ... organization,s Council on Basic Cardiovascular Sciences., Nguyen, who ... 2005, specializes in cellular engineering. Her research also ... therapies., Liping Tang, interim chairman of the UT ...
... Houser, PhD, FAHA, Director of the Cardiovascular Research Center ... studying the heart for nearly three and a half ... to cardiovascular research, work that led to his recent ... Association (AHA) the Basic Cardiovascular Science (BCVS) Council ...
Cached Biology News:Women prescribed combination HRT should use caution when taking apigenin supplement, MU study finds 2Temple's Dr. Steven Houser recognized by the American Heart Association 2Temple's Dr. Steven Houser recognized by the American Heart Association 3
Polio component type I...
Glucagon-like peptide-1 (GLP-1 (1-36) amide)...
... comprehensive microarray service for systematic discovery ... non-coding RNAs (ncRNAs) using a novel ... which enables highly sensitive and specific ... This comprehensive service includes custom probe ...
... LC Sciences provides a comprehensive ... protein kinase substrate (PKS) peptide microarrays ... proteomic scale kinase profiling, quantitative measurement ... discovery research. This comprehensive service includes ...
Biology Products: